| # | Drug | Count |
|---|---|---|
| 0 | OLANZAPINE | 26 |
| 1 | QUETIAPINE | 26 |
| 2 | ARIPIPRAZOLE | 17 |
| 3 | OLANZAPINE PAMOATE | 16 |
| 4 | QUETIAPINE FUMARATE | 15 |
| 5 | CITALOPRAM | 13 |
| 6 | CITALOPRAM HYDROBROMIDE | 13 |
| 7 | METFORMIN | 12 |
| 8 | ZIPRASIDONE HCL | 10 |
| 9 | RISPERIDONE | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZIPRASIDONE HCL | 10 | 0.0038 |
| 1 | ZIPRASIDONE | 7 | 0.0019 |
| 2 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | 1 | 0.0008 |
| 3 | ASENAPINE MALEATE | 4 | 0.0005 |
| 4 | OLANZAPINE PAMOATE | 16 | 0.0004 |
| 5 | OLANZAPINE | 26 | 0.0004 |
| 6 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE | 1 | 0.0003 |
| 7 | PENTOXIFYLLINE | 1 | 0.0002 |
| 8 | IRBESARTAN AND HYDROCHLOROTHIAZIDE | 1 | 0.0002 |
| 9 | GEMFIBROZIL | 2 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 1 | Serotonin Reuptake Inhibitor [EPC] | 13 | 0.0001 |
| 2 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 8 | 0.0001 |
| 3 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | Atypical Antipsychotic [EPC] | 45 | 0.0001 |
| 5 | Xanthine Oxidase Inhibitor [EPC] | 7 | 0.0000 |
| 6 | Typical Antipsychotic [EPC] | 1 | 0.0000 |
| 7 | Angiotensin Converting Enzyme Inhibitor [EPC] | 4 | 0.0000 |
| 8 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 9 | Insulin Analog [EPC] | 12 | 0.0000 |